<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03620331</url>
  </required_header>
  <id_info>
    <org_study_id>Peri-implantitis_ImmediateSurg</org_study_id>
    <nct_id>NCT03620331</nct_id>
  </id_info>
  <brief_title>Surgical Treatment of Peri-implantitis With and Without an Initial Non-surgical Approach</brief_title>
  <official_title>Surgical Treatment of Peri-implantitis With and Without an Initial Non-surgical Approach: a Multi-center Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Complutense de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Policlinico Umberto I</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Turin, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Osteology Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Complutense de Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, surgeon and outcome assessor blinded, multi-centric, superiority trial with two
      parallel groups and a 1:1 allocation ratio with the aim of comparing the surgical treatment
      of severe peri-implantitis with or without an initial non surgical approach.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease Resolution</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Defined as implant survival with no PPD≥5 mm with concomitant BoP or suppuration, and bone loss ≤ 0.5 mm between 2 weeks post-surgery and follow up visits (Sanz et al. 2012; Giannobile et al. 2014; Carcuac et al. 2016).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Probing Pocket Depth changes</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Measured from the mucosal margin to the bottom of the probeable pocket.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Peri-Implantitis</condition>
  <arm_group>
    <arm_group_label>Non Surgical + Surgical</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non surgical approach (NS) followed by surgical treatment (S) of peri-implantitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immediate Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Direct surgical approach (S), without a previous non surgical approach</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery with a previous non-surgical approach</intervention_name>
    <description>Non-surgical phase done prior to the surgical treatment of peri-implantitis</description>
    <arm_group_label>Non Surgical + Surgical</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery without a previous non-surgical approach</intervention_name>
    <description>Non-surgical phase not done prior to the surgical treatment of peri-implantitis</description>
    <arm_group_label>Immediate Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Any patient having at least one implant affected by severe peri-implantitis, being at least
        18 years old and able to sign an informed consent form will be potentially eligible for
        this trial.

        Severe peri-implantitis will be defined as peri-implant probing pocket depth [PPD] ≥6 mm in
        at least 1 site of the implant, together with bleeding and/or suppuration on probing [BoP
        and/or SoP, respectively] and radiographically documented marginal bone loss ≥3 mm (Carcuac
        et al. 2016) on implants in function by at least 1 year. In case of absence of baseline
        radiographs, the reference point for baseline bone levels will be considered where bone was
        likely to be at implant placement.

        Exclusion Criteria:

        Patients fitting to all the inclusion criteria as above will be not included in the study
        if they appear to be unable to attend to the study-related procedures (including the
        follow-up visits) or if one or more of the following systemic or local exclusion criteria
        are found in the enrolment phase.

        Systemic primary exclusion criteria:

          -  compromised general health which contraindicates the study procedures (ASA IV-VI
             patients);

          -  systemic diseases which could influence the outcome of the therapy (uncontrolled
             diabetes mellitus);

          -  pregnant or nursing women;

          -  chronic use of corticosteroids or NSAID or immune-modulator drugs (any type and any
             dose);

          -  patients who need use of medications affecting bone metabolism or peri-implant mucosa
             (bisphosphonates, any type and any dose).

        Local primary exclusion criteria:

          -  history of peri-implantitis treatment on implants to be included in the study
             (included topical antibiotics);

          -  hopeless implants (e.g. mobility) to be included in the study.

        Secondary exclusion criteria:

        - uncompliant patients (poor oral hygiene 2 weeks after OHI).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariano Sanz Alonso</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Periodontology, University Complutense Madrid, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luca Cordaro</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Periodontology and Prosthodontics, &quot;Umberto I&quot; Policlinic - &quot;G. Eastman&quot; Section</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario Romandini</last_name>
    <role>Study Director</role>
    <affiliation>Department of Periodontology, University Complutense Madrid, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Policlinico Umberto I - &quot;G. Eastman&quot; Section - Department of Periodontology</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Surgical Sciences, C.I.R. Dental School, University of Turin</name>
      <address>
        <city>Turin</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Periodontology, University Complutense Madrid, Spain</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2018</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

